ArticleCancer2019

The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer.

Manvi Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.